Surprise setback for lung fibrosis drug highlights trial challenges

被引：0

|

作者：

不详

机构：

来源：

NATURE REVIEWS DRUG DISCOVERY | 2010年 / 9卷 / 07期

关键词：

D O I：

10.1038/nrd3224

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：506 / 506

页数：1

相关论文

共 50 条

[1] Surprise setback for lung fibrosis drug highlights trial challenges
Nature Reviews Drug Discovery, 2010, 9 : 506 - 506
[2] SYNERGEN STOCK PLUNGES AFTER DRUG TRIAL SETBACK
THAYER, A
CHEMICAL & ENGINEERING NEWS, 1993, 71 (09) : 7 - 7
[3] Lupus Drug Is Approved Despite Previous Clinical Trial Setback
Kuehn, Bridget M.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (11): : 1000 - 1000
[4] Challenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease
Ibrahim, Basma M.
Tsifansky, Michael D.
Yang, Yan
Yeo, Yoon
EXPERT OPINION ON DRUG DELIVERY, 2011, 8 (04) : 451 - 466
[5] Innovative highlights of clinical drug trial design
Chen, Daohong
Qi, Eric Yining
TRANSLATIONAL RESEARCH, 2020, 224 : 71 - 77
[6] FLAWED PREPRINT HIGHLIGHTS CHALLENGES OF COVID DRUG STUDIES
Reardon, Sara
NATURE, 2021, 596 (7871) : 173 - 174
[7] Antiviral drug inhibits lung fibrosis
Jessica McHugh
Nature Reviews Rheumatology, 2017, 13 : 696 - 696
[8] Antiviral drug inhibits lung fibrosis
McHugh, Jessica
NATURE REVIEWS RHEUMATOLOGY, 2017, 13 (12) : 696 - 696
[9] Flawed ivermectin preprint highlights challenges of COVID drug studies
Sara Reardon
Nature, 2021, 596 : 173 - 174
[10] Panobinostat clinical trial highlights the challenges towards an HIV cure
Palmer, Clovis S.
Crowe, Suzanne M.
LANCET HIV, 2014, 1 (03): : E103 - E103

← 1 2 3 4 5 →